Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of SP Shz TIV vs Hualan TIV in Healthy Chinese Adults
NCT03344029Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2017
- Primary completion
- May 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of trivalent influenza vaccine in influenza, sponsored by Sanofi. Started Nov 2017; status: completed.
02
Drugs
trivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03344029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03344029.